Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study.
Chung-Feng HuangChia-Yen DaiChih-Wen WangPo-Cheng LiangYu-Ju WeiPei-Chien TsaiTyng-Yuan JangPo-Yao Hsunull Jia-Jung LeeSheng-Wen NiuJiun-Chi HuangMing-Lun YehChing-I HuangMing-Yen HsiehYi-Hung LinSzu-Chia ChenYi-Wen ChiuJee-Fu HuangJer-Ming ChangShang-Jyh HwangWan-Long ChuangMing-Lung Yunull nullPublished in: Clinical kidney journal (2023)
The link-to-care project proved the concept of "treatment as prevention" by which HCV microelimination helps to prevent reinfection and new infections in the HD population.Trial registration: ClinicalTrials.gov identifier: NCT03803410 and NCT03891550.
Keyphrases
- hepatitis c virus
- quality improvement
- healthcare
- palliative care
- human immunodeficiency virus
- study protocol
- chronic kidney disease
- phase iii
- end stage renal disease
- peritoneal dialysis
- pain management
- phase ii
- randomized controlled trial
- stem cells
- combination therapy
- chronic pain
- health insurance
- affordable care act
- open label
- double blind